Boehringer India Chief On Putting Pedal To Metal For Digital Engagements

COVID-19 and the related lockdown has sharply curtailed pharma’s face-to-face interactions with healthcare professionals. Boehringer Ingelheim India managing director Sharad Tyagi shares insights on the “extraordinary surge” in the usage of digital platforms during these challenging times. The German multinational has been able to connect with over 30,000 HCPs across the country via digital channels.

Sharad Tyagi
BI India managing director Sharad Tyagi

The coronavirus pandemic has ravaged nations across the world, putting hospitals and healthcare professionals under tremendous strain as they deal with the surge in patients and a string of other challenges. Pharma, in turn, has had to rapidly re-adjust customer engagement strategies, fast-tracking digital initiatives faced with limited or no access to some HCPs.

In an interview with Scrip, Boehringer Ingelheim India managing director Sharad Tyagi outlined various digital initiatives being deployed by the firm to keep the connection with HCPs strong, while also underscoring that

More from Business

More from Scrip